Strategies for development of hypoallergenic wheat genotypes

Jacek Waga

j.waga@ihar.edu.pl
Zakład Oceny Jakości i Metod Hodowli Zbóż, IHAR, Kraków (Poland)

Jerzy Zientarski


Zakład Oceny Jakości i Metod Hodowli Zbóż, IHAR, Kraków (Poland)

Abstract

Gliadins are one of the most important components in many foodstuffs produced from wheat seed, so they play a significant role in the human diet. However, for people suffering gluten intolerance they may be strong food allergens and in the case of celiac patients – even toxic. This is a serious problem connected with food safety and quality. Immunoreactivity of gliadins extracted from chosen wheat genotypes (species, cultivars and hybrid lines) was investigated. Based on ELISA and skin prick tests binding of gliadin proteins with specific antigliadin antibodies as well as human sera containing IgE antibodies to gluten was analysed. Hybrid genotypes containing a unique composition of gliadins coded by chromosomes 1B and 1D were identified. They showed decreased immunoreactivity in comparison with parental forms. Similar effect was observed in the case of wild progenitors of common wheat: Triticum monococcum and Triticum dicoccum. Differentiation of the analysed wheat species and lines in respect of immunoreactive properties suggest possibility of using genetics and plant breeding methods in production of new hypoallergic wheat genotypes.

Supporting Agencies

Scientific work financed by the Minister of Science in the years 2004–2007 as a research project ordered no. PBZ-KBN-097/P06/2003

Keywords:

gliadins, celiac, allergies

Bürk K., Melms A., Schulz J. B., Dichgans J., Effectiveness of Intravenous Immnoglobulin therapy in cerebellar ataxia associated with gluten sensitivity. Ann. Neurol., 2001, 50 (6), 827 — 828.
Google Scholar

Brown T. A. 2001. Genomy. Wydawnictwa Naukowe PWN. Warszawa: 85 — 110.
Google Scholar

Buchanan B., Adamidi C., Lozano R. M., Yee B. C., Momma M., Kobrehel K., Ermel R., Frick O. L. 1997. Thioredoxin-linked mitigation of allergic responses to wheat. Proc. Natl. Acad. Sci. Vol 94: 5372 — 5377.
Google Scholar

Buchanan B., Kobrehel K., Yee B. C., Lozano R., Frick O. L., Ermel R. 2001. Neutralization of food allergens by thioredoxin. U.S. patent No. 6,190,723 B1.
Google Scholar

Czerwionka-Szaflarska M., Muller L. 2001. Alergiczne podłoże chorób przewodu pokarmowego. Ter. i Leki 51 (4): 15 — 18.
Google Scholar

De Ritis G., Auricchio G., Jones H. H., Lew E. J. L., Bernardin J. E., Kasarda D. D., In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology, 1988, 94, 41 — 49.
Google Scholar

Green P.H.R., Jabri B. 2003. Celiac disease. Lancet Vol. 362: 383 — 391.
Google Scholar

Ikezawa Z., Tsubaki K., Yokota S. 1994. Effect of hypoallergenic wheat (HAW-A1) on atopic dermatitis (AD) with wheat allergy, and its antigenic analysis using sera from patients with AD. Acta Derm. Venerol. 43(6):679 — 688.
Google Scholar

Joint FAO/WHO Food Standards Programme. Codex Alimentarius Commission. Codex Stan, 1981: 118.
Google Scholar

Kasarda D. D. 1994. Toxic cereal grains in celiac disease. Conleth Feighery and Cliona O'Farrelly Editors, Proceedings of the Sixth International Symposium on Celiac Disease held at Trinity College, Dublin in July 1992: 203 — 220.
Google Scholar

Kobrehel K., Wong J. H., Balogh K., Kiss E., Yee B. C., Buchanan B. B. 1992. Specific reduction of wheat storage proteins by thioredoxin h. Plant Physiol. 99: 919 — 924.
Google Scholar

Kuipers A. G. J., Jacobsen E., Visser G. F. 1997. Applications of antisense technology in plants. in: Antisense technology: a practical approach. Lichtenstein C., Nellen W. (eds.) IRL Press at Oxford University Press: 191 — 219.
Google Scholar

Mc Mowat A. 2003. Coeliac disease — a meeting point for genetics, immunology and protein chemistry. Lancet, Vol. 361: 1290 — 1292.
Google Scholar

Palosuo K., Varionen E., Kekki O. M., Klemola T., Kalkkinen N., Alenius H., Reunala T. 2001. Wheat ω-5 gliadin is a major allergen in children with immediate allergy to ingested wheat. J. Allergy Clin. Immunol. Vol.108, No.4:634 — 638.
Google Scholar

Rujner J. 1993. Celiakia — postacie kliniczne i rozpoznawanie. Klinika, Vol. 2, No. 4 (8): 24 — 26.
Google Scholar

Shou-Wang Q., Bergseng E., Molberg Q., Jung G., Fleckenstein B., Sollid L. M. 2005. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ-2 molecule in coeliac disease: importance of proline spacing and glutamine deamidation. J. Immunol. 175: 254 — 261.
Google Scholar

Wong J. H., Kobrehel K., Nimbona C., Yee B. C., Balogh A., Kiss F., Buchanan B. B. 1993. Thioredoxin and bread wheat. Cereal Chem. Vol. 70, No. 1: 113 — 114.
Google Scholar

Vissers M., Doekes G., Heederik D. 2001. Exposure to wheat allergen and fungal α-amylase in the homes of bakers. Clin. Exp. Allergy Vol. 31: 1577 — 1582.
Google Scholar

Zwolińska-Wcisło M., Galicka-Latała D. 2004. Celiakia u dorosłych: rozpoznanie, obraz kliniczny, leczenie. Alergologia, Immunologia. 2, 2/3: 44 — 47.
Google Scholar


Published
2007-06-29

Cited by

Waga, J. and Zientarski, J. (2007) “Strategies for development of hypoallergenic wheat genotypes”, Bulletin of Plant Breeding and Acclimatization Institute, (244), pp. 79–90. doi: 10.37317/biul-2007-0047.

Authors

Jacek Waga 
j.waga@ihar.edu.pl
Zakład Oceny Jakości i Metod Hodowli Zbóż, IHAR, Kraków Poland

Authors

Jerzy Zientarski 

Zakład Oceny Jakości i Metod Hodowli Zbóż, IHAR, Kraków Poland

Statistics

Abstract views: 55
PDF downloads: 36


License

Copyright (c) 2007 Jacek Waga, Jerzy Zientarski

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Upon submitting the article, the Authors grant the Publisher a non-exclusive and free license to use the article for an indefinite period of time throughout the world in the following fields of use:

  1. Production and reproduction of copies of the article using a specific technique, including printing and digital technology.
  2. Placing on the market, lending or renting the original or copies of the article.
  3. Public performance, exhibition, display, reproduction, broadcasting and re-broadcasting, as well as making the article publicly available in such a way that everyone can access it at a place and time of their choice.
  4. Including the article in a collective work.
  5. Uploading an article in electronic form to electronic platforms or otherwise introducing an article in electronic form to the Internet or other network.
  6. Dissemination of the article in electronic form on the Internet or other network, in collective work as well as independently.
  7. Making the article available in an electronic version in such a way that everyone can access it at a place and time of their choice, in particular via the Internet.

Authors by sending a request for publication:

  1. They consent to the publication of the article in the journal,
  2. They agree to give the publication a DOI (Digital Object Identifier),
  3. They undertake to comply with the publishing house's code of ethics in accordance with the guidelines of the Committee on Publication Ethics (COPE), (http://ihar.edu.pl/biblioteka_i_wydawnictwa.php),
  4. They consent to the articles being made available in electronic form under the CC BY-SA 4.0 license, in open access,
  5. They agree to send article metadata to commercial and non-commercial journal indexing databases.